0001209191-21-025490.txt : 20210405
0001209191-21-025490.hdr.sgml : 20210405
20210405193233
ACCESSION NUMBER: 0001209191-21-025490
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210402
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eliades George Christopher
CENTRAL INDEX KEY: 0001855251
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39112
FILM NUMBER: 21807498
MAIL ADDRESS:
STREET 1: C/O OYSTER POINT PHARMA, INC.
STREET 2: 202 CARNEGIE CENTER, SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oyster Point Pharma, Inc.
CENTRAL INDEX KEY: 0001720725
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 811030955
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 382-9032
MAIL ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-02
0
0001720725
Oyster Point Pharma, Inc.
OYST
0001855251
Eliades George Christopher
C/O OYSTER POINT PHARMA, INC.
202 CARNEGIE CENTER, SUITE 109
PRINCETON
NJ
08540
1
0
0
0
Common Stock
2021-04-02
4
A
0
19935
0.00
A
19935
D
Common Stock
2021-04-02
4
A
0
1650
0.00
A
21585
D
This security represents restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of common stock of the Issuer.
1/3 of the RSUs will vest in three equal annual installments, with 1/3 vesting on the one (1) year anniversary of April 2, 2021, and one-third (1/3) of the RSUs vesting annually thereafter on April 2, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date.
1/3 of the RSUs will vest monthly on the same day of the month beginning on April 8, 2021 until the Company's Annual Meeting of Stockholders to be held in 2021; provided, however, if all of such RSUs are not fully vested at the Company's next Annual Meeting, any such remaining RSUs will vest on the date of the Company's next Annual Meeting, in each case, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date.
/s/ Brandon Fenn, Attorney-in-Fact
2021-04-05